SCM
TECH icon

Suvretta Capital Management’s Bio-Techne TECH Stock Holding History

Suvretta Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,600
Closed -$208K – 112
2024
Q3 		$208K Buy
+2,600
New +$195K 0.01% 98
2024
Q1 		– Sell
-2,600
Closed -$201K – 112
2023
Q4 		$201K Buy
+2,600
New +$171K 0.01% 88
2023
Q3 		– Sell
-2,600
Closed -$212K – 102
2023
Q2 		$212K Buy
+2,600
New +$209K 0.01% 99
2023
Q1 		– Sell
-2,600
Closed -$215K – 111
2022
Q4 		$215K Buy
+2,600
New +$206K 0.01% 87

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Suvretta Capital Management's TECH Position: Q4 2024 in Review

Suvretta Capital Management sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 2,600 shares — an estimated $208K sold.

Suvretta Capital Management first reported a position in TECH in Q4 2022 and held it in 4 quarters. The position peaked at $215K in Q4 2022. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

  • Suvretta Capital Management reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
  • Suvretta Capital Management sold 2,600 Bio-Techne shares in Q4 2024, an estimated $208K.
  • Suvretta Capital Management first reported a position in Bio-Techne in Q4 2022 and held it in 4 quarters.
  • Suvretta Capital Management's Bio-Techne position peaked at $215K in Q4 2022.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Suvretta Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.